Literature DB >> 15363039

Key molecular events in puromycin aminonucleoside nephrosis rats.

Na Guan1, Jie Ding, Jianghong Deng, Jingjing Zhang, Jiyun Yang.   

Abstract

Nephrin, podocin and alpha-actinin are all involved in proteinuria, but it is unclear which molecular event plays a crucial role during the development of proteinuria. Immunofluorescence staining and real-time quantitative polymerase chain reaction were used to study the glomerular expression of these molecules in puromycin aminonucleoside (PAN) nephrosis. Morphometric methods were applied to evaluate the podocyte foot process (FP) morphology. Two days after PAN injection, nephrin and podocin staining became discontinuous, podocin intensity decreased and FP swelled. Nephrin protein and mRNA decreased at day 5. Both podocin and nephrin intensity decreased dramatically when heavy proteinuria occurred, but nephrin mRNA was regained. When proteinuria disappeared, podocin recovered whereas nephrin did not (P = 0.02); alpha-actinin intensity increased (P = 0.009) and the distribution changed. The podocyte FP volume density correlated negatively with nephrin (r = -0.78, P = 0.0001) and podocin immunofluorescence intensity (r = -0.76, P = 0.0001). We conclude that, before the onset of proteinuria, the first response was the nephrin and podocin distribution change, podocin protein decrease and swollen FP; the podocin quantitative change was earlier than nephrin. Podocin and nephrin distribution and the protein level was associated with proteinuria more closely than their mRNA level. The delayed alpha-actinin induction might be a reparative response.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15363039     DOI: 10.1111/j.1440-1827.2004.01683.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  15 in total

1.  Protective effects of PPARγ agonist in acute nephrotic syndrome.

Authors:  Yiqin Zuo; Hai-Chun Yang; Sebastian A Potthoff; Behzad Najafian; Valentina Kon; Li-Jun Ma; Agnes B Fogo
Journal:  Nephrol Dial Transplant       Date:  2011-05-12       Impact factor: 5.992

2.  Slit diaphragm protein Neph1 and its signaling: a novel therapeutic target for protection of podocytes against glomerular injury.

Authors:  Ehtesham Arif; Yogendra S Rathore; Babita Kumari; Fnu Ashish; Hetty N Wong; Lawrence B Holzman; Deepak Nihalani
Journal:  J Biol Chem       Date:  2014-02-19       Impact factor: 5.157

3.  Expression and function of C/EBP homology protein (GADD153) in podocytes.

Authors:  Martin F Bek; Michael Bayer; Barbara Müller; Stefan Greiber; Detlef Lang; Albrecht Schwab; Christian August; Erik Springer; Rolf Rohrbach; Tobias B Huber; Thomas Benzing; Hermann Pavenstädt
Journal:  Am J Pathol       Date:  2006-01       Impact factor: 4.307

4.  High-glucose and advanced glycosylation end products increased podocyte permeability via PI3-K/Akt signaling.

Authors:  Tae-Sun Ha
Journal:  J Mol Med (Berl)       Date:  2010-01-08       Impact factor: 4.599

Review 5.  The role of toxicoproteomics in assessing organ specific toxicity.

Authors:  B Alex Merrick; Frank A Witzmann
Journal:  EXS       Date:  2009

6.  Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.

Authors:  Andrea Becker-Merok; Manar Kalaaji; Kaia Haugbro; Cathrin Nikolaisen; Kirsten Nilsen; Ole Petter Rekvig; Johannes C Nossent
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

7.  Renoprotective effect of topiroxostat via antioxidant activity in puromycin aminonucleoside nephrosis rats.

Authors:  Yosuke Kawamorita; Takeshi Shiraishi; Yoshifuru Tamura; Takanori Kumagai; Shigeru Shibata; Yoshihide Fujigaki; Makoto Hosoyamada; Takahiko Nakagawa; Shunya Uchida
Journal:  Physiol Rep       Date:  2017-08

8.  Puromycin aminonucleoside modulates p130Cas of podocytes.

Authors:  Tae-Sun Ha; Ji-Young Choi; Hye-Young Park
Journal:  Korean J Pediatr       Date:  2012-10-29

9.  aPKCλ maintains the integrity of the glomerular slit diaphragm through trafficking of nephrin to the cell surface.

Authors:  Daisuke Satoh; Tomonori Hirose; Yutaka Harita; Chikara Daimon; Tomonori Harada; Hidetake Kurihara; Akio Yamashita; Shigeo Ohno
Journal:  J Biochem       Date:  2014-04-03       Impact factor: 3.387

10.  Pioglitazone Enhances the Beneficial Effects of Glucocorticoids in Experimental Nephrotic Syndrome.

Authors:  S Agrawal; M A Chanley; D Westbrook; X Nie; T Kitao; A J Guess; R Benndorf; G Hidalgo; W E Smoyer
Journal:  Sci Rep       Date:  2016-05-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.